Skip to main content

Table 2 Multivariate Cox regression analyses for biochemical failure in the entire cohort (n = 1176)

From: Comparison between preoperative and real-time intraoperative planning 125I permanent prostate brachytherapy: long-term clinical biochemical outcome

Factor Model 1 Model 2
  Hazard ratio (95% CI) p-value Hazard ratio (95% CI) p-value
Age 0.99 (0.94–1.03) 0.49 1.01 (0.95–1.07) 0.78
PSA 1.09 (1.02–1.17) 0.011 1.08 (0.96–1.22) 0.22
Gleason 1.02 (0.72–1.46) 0.90 1.55 (0.73–3.27) 0.25
Clinical T stage 1.32 (0.59–2.94) 0.49 1.64 (0.48–5.55) 0.43
ADT 0.55 (0.31–0.99) 0.045 0.20 (0.07–.057) 0.002
Technique 0.13 (0.07–0.23) <0.001 -----------
BED ----------- 0.987 (0.981–0.993) <0.001
  1. PSA, Prostate-specific antigen; ADT, Androgen deprivation therapy; BED, Biological effective dose.